IMU

0.00%

5.9¢ imugene limited

Wow, this person has been consistently accurate with their...

First 1031 Last

Share
Profile

Follow
kira1256

158 Posts.

37

02/11/23

21:05

Post #: 70699433
Share

Originally posted by Mason14: ↑

Lot's of talking going on here.

I'm wondering if anyone has addressed the fact that there is limited preclinical evidence that has demonstrated a significant benefit from intravenous administration of CF33 either as a single agent or in combination with an anti-PDL1 in every murine model tested? In cases were there may have been benefit, the clinical trial either administered the OV/combination immediately after transfection into the murine model or did not have a single-agent PDL1 arm.

Intratumoral administration of anti-cancer agents for metastatic cancers is not and has never been an effective method of administration. In metastases, cancer has spread around the body and in most cases the cancer sites are not accessible by a needle (just look below). Notice in the most recent announcement that they only accepted patients that had cancers close to the skin, and it was those specific cancer locations they were examining. Need I say that cancers in early stages that are close to the skin are removed surgically, so who exactly is your target market?

Oncolytic viral therapy has always struggled to penetrate the tumor microenvironment, survive the immune system, and display significant efficacy in the clinic, which is why it's worth just $23-84M globally. Not to mention it is a crowded space with 114 clinical trials currently underway.

If CF33 as a single agent or in combination with any drug can't demonstrate a significant benefit administered intravenously, then it will fail in the clinic and commercialisation. I think IMU is about to head below 10c as people begin to understand the significant clinical and commercial risks associated with CF33, and with the realisation that HER-VAXX was a substandard therapy hyped as superior.

Expand

Wow, this person has been consistently accurate with their predictions.

IMU Price at posting: 4.3¢ Sentiment: Sell Disclosure: Not Held
2 Upvote

0 Great analysis

Reply

Top Stories

BRX

Belararox delineates another porphyry in Argentina at Tambo South

Plagues precede widespread power shifts. We’re living in one – and minerals are at the fore

FHE

Frontier Energy achieves key milestone for Waroona energy project

GYG

Guzman Y Gomez shot up nearly 40% in first hour of trades. Can it last?

STX

Strike Energy secures $153 million for Perth Basin gas projects

AML

Cultural heritage agreement puts Walford Creek exploration back on the map

SBW

Shekel Brainweigh CEO Nir Leshem weighs in on AI adoption ahead of FY25

ASX Market Update: Shares fall flat as GYG soars on debut | 20 June, 2024

With financials holding the fort, materials must step up with some heavy lifting to stimulate stocks

RDN

If you thought lithium was dead, think again. The Pilbara will be central to the next upswing

There are more pages in this discussion • 57 more messages in this thread...

First 1031 Last

Add IMU (ASX) to my watchlist

(20min delay)
Last 5.9¢		Change 0.000(0.00%)		Mkt cap ! $431.8M

Open	High	Low	Value	Volume
5.9¢	5.9¢	5.6¢	$1.037M	17.94M

Buyers (Bids)

No.	Vol.	Price($)
8	1882949	5.8¢

Sellers (Offers)

Price($)	Vol.	No.
5.9¢	399643	3

View Market Depth

No.	Vol.	Price($)
8	1882949	0.058
11	3369960	0.057
27	4811046	0.056
28	4598665	0.055
10	310001	0.054

Price($)	Vol.	No.
0.059	399643	3
0.060	2631845	18
0.061	773907	4
0.062	2227969	6
0.063	243179	3

Last trade - 16.10pm 21/06/2024 (20 minute delay)

IMU (ASX) Chart

Wow, this person has been consistently accurate with their...

Belararox delineates another porphyry in Argentina at Tambo South

Plagues precede widespread power shifts. We’re living in one – and minerals are at the fore

Frontier Energy achieves key milestone for Waroona energy project

Guzman Y Gomez shot up nearly 40% in first hour of trades. Can it last?

Strike Energy secures $153 million for Perth Basin gas projects

Cultural heritage agreement puts Walford Creek exploration back on the map

Shekel Brainweigh CEO Nir Leshem weighs in on AI adoption ahead of FY25

ASX Market Update: Shares fall flat as GYG soars on debut | 20 June, 2024

With financials holding the fort, materials must step up with some heavy lifting to stimulate stocks

If you thought lithium was dead, think again. The Pilbara will be central to the next upswing

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Wow, this person has been consistently accurate with their...

Top Stories

Belararox delineates another porphyry in Argentina at Tambo South

Plagues precede widespread power shifts. We’re living in one – and minerals are at the fore

Frontier Energy achieves key milestone for Waroona energy project

Guzman Y Gomez shot up nearly 40% in first hour of trades. Can it last?

Strike Energy secures $153 million for Perth Basin gas projects

Cultural heritage agreement puts Walford Creek exploration back on the map

Shekel Brainweigh CEO Nir Leshem weighs in on AI adoption ahead of FY25

ASX Market Update: Shares fall flat as GYG soars on debut | 20 June, 2024

With financials holding the fort, materials must step up with some heavy lifting to stimulate stocks

If you thought lithium was dead, think again. The Pilbara will be central to the next upswing

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News